Extracellular vesicles (EVs), as endogenous nanoscale delivery platforms, have garnered significant attention due to their high biocompatibility, low immunogenicity, and intrinsic ability to cross physiological barriers. However, the clinical translation of natural EVs is hindered by inherent limitations, including p...
Zhouming Cheng, Wen-Tao Zhao, Min Wang et al.· iNew Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.